Form 4 for ACAD ACADIA PHARMACEUTICALS INC
Accepted 2026-05-05 18:00:18 ET · period of report 2026-05-01 · accession 0001899977-26-000007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-05-05 18:00 | 2026-05-01 | ACAD | Schneyer Mark C. | EVP, CFO | M - OptEx | — | +6,815 | 69.7K | +11% | — |
| D | 2026-05-05 18:00 | 2026-05-04 | ACAD | Schneyer Mark C. | EVP, CFO | S - Sale+OE | $21.79 | -3,506 | 66.1K | -5% | -$76.4K |
| D | 2026-05-05 18:00 | 2026-05-01 | ACAD | Schneyer Mark C. | EVP, CFO | M - OptEx | $0.00 | -6,815 | 6,815 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-01 | M | A | 6,815 | — | 69,651 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. |
| 2 | Common | Common Stock | 2026-05-04 | S | D | 3,506 | $21.79 | 66,145 | D | — | — | (F2) The mandatory sales reported in this Form 4 were made to cover withholding taxes and tax related items imposed by the Issuer in connection with the vesting of restricted stock units, and it is intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c). (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.79 to $21.7932, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. |
| 3 | Derivative | Restricted Stock Units | 2026-05-01 | M | D | 6,815 | $0.00 | 6,815 | D | — · — to — | 6,815 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. (F4) The restricted stock units vest in four equal annual installments beginning May 1, 2024. (F4) The restricted stock units vest in four equal annual installments beginning May 1, 2024. |